TITLE

The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder

AUTHOR(S)
Coghill, David
PUB. DATE
October 2010
SOURCE
CNS Drugs;2010, Vol. 24 Issue 10, p843
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Quality of life (QOL) describes an individual's subjective perception of their position in life as evidenced by their physical, psychological and social functioning. Although an established outcome measure in physical health, QOL has more recently become an increasingly important measure in mental health clinical work and research. This article reviews the evidence describing the impact of medications on QOL in attention-deficit hyperactivity disorder (ADHD). Databases were searched for research studies describing the effects of medication on QOL in ADHD: 25 relevant studies were identified. Most (n = 20) of these studies have focused on children and adolescents, and most have investigated a single molecule, atomoxetine (n= 15), with relatively few studies investigating methylphenidate (n = 5), amfetamines (n = 4) and manifaxine (n= 1). These studies support a positive short-term effect of medication on QOL in ADHD for children, adolescents and adults that mirrors, to some extent, the effects of these medications on ADHD symptoms, although with smaller effect sizes. Notwithstanding measurement issues, it will continue to be important that those designing and conducting clinical trials in ADHD, including both pharmacological and non-pharmacological treatments, continue to include measures of QOL as secondary outcome measures. In particular, information about QOL effects in adults and in subjects of all ages taking methylphenidate and amfetamine treatments is urgently needed. The lack of systematic studies of the impact on QOL of psychological therapies, either on their own or in multimodal combinations with medication, is a serious omission that should be urgently addressed.
ACCESSION #
55821996

 

Related Articles

  • Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?  // Child & Adolescent Psychiatry & Mental Health;2011, Vol. 5 Issue 1, p26 

    The article presents a research which examines the efficacy of osmotic, controlled-release (OROS©) methylphenidate (MPH) in treating children and adolescents with attention-deficit hyperactivity disorder (ADHD), and whether the treatment response is different between children and adolescents....

  • Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder. Wu, Eric Q.; Hodgkins, Paul; Ben-Hamadi, Rym; Setyawan, Juliana; Xie, Jipan; Sikirica, Vanja; Du, Ella X.; Yan, Sherry Y.; Erder, M. Haim // CNS Drugs;2012, Vol. 26 Issue 7, p581 

    Background: Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder that impairs the quality of life for patients and their families and is associated with considerable direct and indirect costs. Pharma-cotherapies for ADHD, including stimulants and non-stimulants, are...

  • Ritalin outperforms Concerta in ADHD study.  // PharmaWatch: CNS;July 2003, Vol. 2 Issue 7, p7 

    Examines the efficacy of the Ritalin Long-Acting drugs on patients with attention deficit hyperactivity disorder. Improvement on the quality of life; Increase on the level of survival; Control on the symptoms of the disease.

  • Does ADHD Even Exist? Breeding, John // Mothering;Jul/Aug2000, Issue 101, p43 

    Focuses on the use of the Ritalin drug as treatment for attention-deficit hyperactivity disorder in the United States. Role of parents and adults in determining psychiatric drug prescription for children; Behavior disorders relieved by the use of Ritalin. INSETS: Suffer the Children?;Ritalin...

  • Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep. Yu-Shu Huang; Ming-Horng Tsai; Guilleminault, Christian // Current Pharmaceutical Design;5/21/2011, Vol. 17 Issue 15, p1450 

    No abstract available.

  • No Association between the Response to Methylphenidate and DRD4 Gene Polymorphism in Korean Attention Deficit Hyperactivity Disorder: A Case Control Study. Hyun Soo Ji; Ki Chung Paik; Woo Sung Park; Myung Ho Lim // Clinical Psychopharmacology & Neuroscience;Apr2013, Vol. 11 Issue 1, p13 

    Objective: Recently the relationship between alleles frequency distribution, drug response and the attention deficit hyperactivity disorder (ADHD), has been actively researched. We investigated the association between the genetic type, alleles and drug response for the dopamine receptor D4...

  • What About the Dam Break Upstream? Börner, Joachim // Deutsches Aerzteblatt International;12/27/2010, Vol. 107 Issue 51/52, p918 

    A letter to the editor is presented in response to the article "The Changing Prevalence of Attention-Deficit/ Hyperactivity Disorder and Methylphenidate Prescriptions: A Study of Data From a Random Sample of Insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007."

  • A Pilot Study of Methylphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive... Connor, Daniel F.; Barkley, Russell A.; Davis, Heather T. // Clinical Pediatrics;Jan2000, Vol. 39 Issue 1, p15 

    Summary: A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or...

  • RITALIN UPDATE FOR COUNSELORS, TEACHERS, AND PARENTS. White, Hazel L.; Rouge, Baton // Education;Winter2003, Vol. 124 Issue 2, p289 

    Ritalin is prescribed primarily to individuals who have attention deficit-hyperactivity disorder (ADHD) or attention deficit disorder (ADD). Ritalin has been found to be safe in the treatment of these conditions. As useful as Ritalin is for these conditions, it has great potentials for abuse....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics